http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 20 Feb 2025 17:11:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Press+Releases/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162 http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html <p class="bwalignc"> <i>-- Acquisition Propels Cosette Into One Of The Leading Companies In Women’s Health and Dermatology in the U.S. --</i> </p><p class="bwalignc"> <i>-- Highly Complementary Business Strengthens Cosette’s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach --</i> </p><p class="bwalignc"> <i>-- Utilizing Mayne Pharma’s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access --</i> </p> <p> BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total http://www.streetinsider.com/Business+Wire/Cosette+Pharmaceuticals+Announces+Acquisition+of+Mayne+Pharma%2C+Transforming+Company+into+a+Leader+in+Women%E2%80%99s+Health+and+Dermatology/24380746.html Thu, 20 Feb 2025 17:11:00 -0500 A.01363117 A.05453562 A.13193403 A.25492582 A.50200948 A.60001732 HLNE MYX O.00046809 O.00163824 O.04453372 O.16791100 O.21136544 O.37053734 O.41197767 O.54607162